Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer

Cristina Raimondi(Sapienza University of Rome), Paola Gazzaniga(Sapienza University of Rome)

Cancers

January 4, 2019

10.3390/cancers11010042

Cited by 49

Related Papers

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system<b>?</b>

|OncoImmunology|2017|78

Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer

|Cancers|2019|31